Back to Search
Start Over
A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study
- Source :
- Clinical Cardiology, 41, 7, pp. 903-909, Clinical Cardiology, 41(7), 903-909. Wiley, Clinical Cardiology, 41, 903-909
- Publication Year :
- 2018
-
Abstract
- Contains fulltext : 196098.pdf (Publisher’s version ) (Open Access) BACKGROUND: Peripheral arterial disease (PAD) is a global health problem that is frequently underdiagnosed and undertreated. Noninvasive tools to predict the presence and severity of PAD have limitations including inaccuracy, cost, or need for intravenous contrast and ionizing radiation. HYPOTHESIS: A clinical/biomarker score may offer an attractive alternative diagnostic method for PAD. METHODS: In a prospective cohort of 354 patients referred for diagnostic peripheral and/or coronary angiography, predictors of >/=50% stenosis in >/=1 peripheral vessel (carotid/subclavian, renal, or lower extremity arteries) were identified from >50 clinical variables and 109 biomarkers. Machine learning identified variables predictive of obstructive PAD; a score derived from the final model was developed. RESULTS: The score consisted of 1 clinical variable (history of hypertension) and 6 biomarkers (midkine, kidney injury molecule-1, interleukin-23, follicle-stimulating hormone, angiopoietin-1, and eotaxin-1). The model had an in-sample area under the receiver operating characteristic curve of 0.85 for obstructive PAD and a cross-validated area under the curve of 0.84; higher scores were associated with greater severity of angiographic stenosis. At optimal cutoff, the score had 65% sensitivity, 88% specificity, 76% positive predictive value (PPV), and 81% negative predictive value (NPV) for obstructive PAD and performed consistently across vascular territories. Partitioning the score into 5 levels resulted in a PPV of 86% and NPV of 98% in the highest and lowest levels, respectively. Elevated score was associated with shorter time to revascularization during 4.3 years of follow-up. CONCLUSIONS: A clinical/biomarker score demonstrates high accuracy for predicting the presence of PAD.
- Subjects :
- Male
Proteomics
medicine.medical_treatment
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
030204 cardiovascular system & hematology
MIDKINE
0302 clinical medicine
Medicine
030212 general & internal medicine
Prospective Studies
Prospective cohort study
Area under the curve
Angiography
General Medicine
Blood Proteins
ASSOCIATION
Middle Aged
SERUM-LEVELS
Peripheral
Catheter
Diagnostic Score
Cardiology
Biomarker (medicine)
BINDING GROWTH-FACTOR
Female
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Clinical Investigations
Revascularization
03 medical and health sciences
Peripheral Arterial Disease
Predictive Value of Tests
Internal medicine
Catheterization, Peripheral
REGRESSION
Humans
Aged
Receiver operating characteristic
RECEPTOR
business.industry
Reproducibility of Results
medicine.disease
EOTAXIN
Stenosis
ANGIOPOIETIN-1
ATHEROSCLEROSIS
RISK-FACTORS
business
Biomarkers
Follow-Up Studies
Subjects
Details
- ISSN :
- 01609289
- Database :
- OpenAIRE
- Journal :
- Clinical Cardiology, 41, 7, pp. 903-909, Clinical Cardiology, 41(7), 903-909. Wiley, Clinical Cardiology, 41, 903-909
- Accession number :
- edsair.doi.dedup.....6014b330807f9e39b03157bf1aa50728